Zura Bio Announces Participation at February Investor Conferences

Zura Bio Limited , a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders, today announced that members of its senior...

Related Keywords

New York ,United States ,Zura Bio ,Kiran Nistala ,Piper Sandler ,Robert Lisicki ,Michael Howell ,Head Of Development ,Healthcare Life Sciences Conference ,Zura Bio Limited Nasdaq ,Zura Bio Limited ,Investor Summit ,Chief Scientific Officer ,Translational Medicine ,Guggenheim Healthcare Talks ,Annual Biotechnology Conference ,Chief Operating Officer ,Annual Healthcare Life Sciences Conference ,Chief Medical Officer ,Private Securities Litigation Reform Act ,Markets ,